Analysed APYX MEDICAL CORP (APYX:NASDAQ) News Sources
New Study Shows Significant Improvement in Cellulite and Skin Laxity with Advanced Minimally Invasive Treatment Utilizing Avéli® and Renuvion®
21-05-2026
yahoo.com
Body by Apyx Takes Center Stage at Miami Swim Week Showcasing Real Patient Transformations and Confidence on the Runway
27-05-2026
yahoo.com
How The Apyx Medical (APYX) Story Is Shifting With AYON, GLP 1 Demand And 2026 Goals
01-06-2026
yahoo.com
Apyx Medical Corporation (APYX): a High Growth Micro-Cap Stock Improving Cellulite and Skin laxity
19-06-2026
yahoo.com
Apyx Medical Corporation to Release Second Quarter of Fiscal Year 2026 Financial Results on August 6, 2026
23-07-2026
yahoo.com
Apyx Medical Corporation to Participate in the Canaccord Genuity 46th Annual Growth Conference
28-07-2026
yahoo.com
Apyx Medical Corp (APYX) (Q2 2026) Earnings Call Highlights: Revenue Surges 22% on Power Lipo ...
07-08-2026
yahoo.com
Apyx Medical Sees GLP-1 Boom Fueling Demand for Renuvion, AYON Body Contouring
12-08-2026
marketbeat.com
What is the current price of APYX MEDICAL CORP (APYX:NASDAQ)?
The current price of APYX MEDICAL CORP (APYX:NASDAQ) is $3.05.
APYX MEDICAL CORP (APYX:NASDAQ) absolute price change since previous trading day?
The absolute price change of APYX MEDICAL CORP (APYX:NASDAQ) since the previous trading day is $-0.03.
APYX MEDICAL CORP (APYX:NASDAQ) percentage price change since previous trading day?
The percentage price change of APYX MEDICAL CORP (APYX:NASDAQ) since the previous trading day is -0.974%.
What is the most recent average sentiment score for APYX MEDICAL CORP (APYX:NASDAQ)?
The most recent average sentiment score for APYX MEDICAL CORP (APYX:NASDAQ) is 77 out of 100.
What is the most recent average sentiment for APYX MEDICAL CORP (APYX:NASDAQ)?
The most recent sentiment for APYX MEDICAL CORP (APYX:NASDAQ) is .
SEC-8K** Filing Available For APYX MEDICAL CORP (APYX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.